OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) CEO Aaron Green acquired 36,920 shares of the stock in a transaction dated Friday, June 12th. The shares were bought at an average price of $0.56 per share, with a total value of $20,675.20. Following the completion of the purchase, the chief executive officer directly owned 1,841,023 shares of the company’s stock, valued at approximately $1,030,972.88. This trade represents a 2.05% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link.
Aaron Green also recently made the following trade(s):
- On Monday, June 15th, Aaron Green acquired 18,702 shares of OneMedNet stock. The stock was purchased at an average cost of $0.54 per share, for a total transaction of $10,099.08.
OneMedNet Price Performance
ONMD stock opened at $0.50 on Wednesday. OneMedNet Corporation has a 12 month low of $0.33 and a 12 month high of $4.22. The company has a market capitalization of $27.27 million, a P/E ratio of -10.02 and a beta of 1.12. The firm’s fifty day simple moving average is $0.86 and its 200-day simple moving average is $0.95.
Institutional Investors Weigh In On OneMedNet
Institutional investors and hedge funds have recently bought and sold shares of the stock. Exencial Wealth Advisors LLC lifted its stake in shares of OneMedNet by 1.3% during the fourth quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock valued at $4,009,000 after buying an additional 45,401 shares during the period. HRT Financial LP purchased a new stake in shares of OneMedNet in the fourth quarter valued at $32,000. Jane Street Group LLC acquired a new position in OneMedNet in the fourth quarter valued at $119,000. State Street Corp boosted its stake in OneMedNet by 41.5% in the 4th quarter. State Street Corp now owns 116,700 shares of the company’s stock worth $128,000 after buying an additional 34,200 shares during the last quarter. Finally, Virtu Financial LLC purchased a new position in shares of OneMedNet during the 4th quarter worth about $48,000. Hedge funds and other institutional investors own 0.95% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities research analysts recently weighed in on ONMD shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of OneMedNet in a research note on Monday, June 1st. Wall Street Zen lowered OneMedNet from a “hold” rating to a “sell” rating in a research report on Saturday, May 23rd. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, OneMedNet presently has a consensus rating of “Sell”.
Read Our Latest Stock Report on ONMD
About OneMedNet
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
See Also
- Five stocks we like better than OneMedNet
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
